Treatment of Urethral Stricture With Urethral Drug Ball

NCT05812482 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 150

Last updated 2023-04-13

No results posted yet for this study

Summary

To evaluate the safety and efficacy of urethral drug balloon catheter in the treatment of urethral stricture.

Conditions

  • Urethral Stricture Less Than 2 cm

Interventions

PROCEDURE

Drug balloon dilatation

The Drug balloon is covered with paclitaxel coating that diffuses the drug into the urethral wall when dilated

PROCEDURE

Direct vision internal urethrotomy (DVIU)

A control subject will choose DVIU surgery until the desired effect is achieved

Sponsors & Collaborators

  • Lepu Medical Technology (Beijing) Co., Ltd.

    lead INDUSTRY

Principal Investigators

  • Jianbing Li · Beijing Tsinghua Changgeng Hospital

  • Jianbin Bi · First Hospital of China Medical University

  • Qiang Fu · Shanghai 6th People's Hospital

  • Shaogang Wang · Tongji Hospital affiliated to Tongji Medical College HUST

  • Xiaoping Zhang · Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

  • Yuanjie Niu · Tianjin Medical University Second Hospital

  • Jinjian Yang · The First Affiliated Hospital of Zhengzhou University

  • Weijun Qin · Air Force Medical University of PLA (the Fourth Military Medical University)

  • Lei Li · First Affiliated Hospital Xi'an Jiaotong University

  • Deyi Luo · West China School of Medicine of Sichuan University

  • Zhansong Zhou · Southwest Hospital, China

  • Wei Yu · Peking University First Hospital

  • Jianwei Wang · Beijing Jishuitan Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-03-31
Primary Completion
2024-10-31
Completion
2025-02-28

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05812482 on ClinicalTrials.gov